Literature DB >> 12457261

Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro.

K Still1, R J Phipps, A Scutt.   

Abstract

The effects of risedronate, alendronate, and etidronate were assessed in calcifying fibroblastic colony-forming unit (CFU-f) cultures of rat bone marrow cells in vitro. Biphasic effects on the formation of bone-like colonies were observed. Treatment with high concentrations (10(-5)-10(-4)M) of alendronate and risedronate caused a total inhibition of colony formation whereas etidronate had relatively little effect. It was also found that intermediate concentrations (10(-6)M) of alendronate and risedronate decreased the formation of colonies displaying osteoblastic characteristics such as alkaline phosphatase expression, collagen accumulation, and calcification. At lower concentrations (10(-9)-10(-7)M), risedronate and alendronate increased the formation of fibroblastic colonies, suggesting a mild anabolic effect, however, the formation of colonies with osteoblastic properties was not affected. Treating the cells with a combination of bisphosphonate and 1 mM geranylgeraniol could to some extent abrogate the cytotoxic effects of alendronate or risedronate, suggesting the involvement of the mevalonate pathway. The colony-stimulating activity of these bisphosphonates was, however, unaffected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457261     DOI: 10.1007/s00223-001-2066-y

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  4 in total

1.  The influence of low-level laser therapy with alendronate irrigation on healing of bone defects in rats.

Authors:  Utkan Kamil Akyol; Sare Sipal; Elif Demirci; Metin Gungormus
Journal:  Lasers Med Sci       Date:  2015-02-17       Impact factor: 3.161

Review 2.  The Role of Geranylgeraniol in Managing Bisphosphonate-Related Osteonecrosis of the Jaw.

Authors:  Kok-Yong Chin; Sophia Ogechi Ekeuku; Anne Trias
Journal:  Front Pharmacol       Date:  2022-05-04       Impact factor: 5.988

3.  Modulation of murine bone marrow-derived CFU-F and CFU-OB by in vivo bisphosphonate and fluoride treatments.

Authors:  M-Y Chou; D Yan; T Jafarov; E T Everett
Journal:  Orthod Craniofac Res       Date:  2009-05       Impact factor: 1.826

Review 4.  Pharmacological management of osteogenesis.

Authors:  Valeria Nardone; Federica D'Asta; Maria Luisa Brandi
Journal:  Clinics (Sao Paulo)       Date:  2014-06       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.